Scientific, medical and industrial issues in breast and ovarian cancer genes research

This paper explores the strategies used by researchers in the study of breast and ovarian cancer genes. Researchers are confronted with a variety of important issues. First, they vie for financial support and recognition both inside and outside their scientific community. Second, they must deal with industry, whose interest lies in the development of potential tests and therapies. Third, they are challenged by important medical questions when financial imperatives threaten to take precedence over health concerns. This study, based on in-depth interviews of three researchers, explores the organization and financing of research, the impact of this research on medicine, and interactions with industry